Youngstown
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
37- Orthopaedic Surgery
- 37
How orthopedic practices structure vendor qualification
Orthopedic groups and surgery centers that bring on a new tissue or biologics supplier typically start with a documentation request rather than a product demonstration. They ask for a certificate of analysis for the lot in question, a donor eligibility summary, and confirmation of how the product is processed and tested before it is released for distribution.
A second step is usually internal: the practice's medical director or compliance lead reviews the regulatory posture of the product category, since Wharton's jelly allografts and exosome preparations are not evaluated the same way as drugs. That review belongs to the practice and its counsel, not to the distributor.
NPI-verified accounts and ordering
Precision Biologics opens accounts only for licensed professionals, and account verification requires a National Provider Identifier confirmed against the NPPES registry. This keeps ordering limited to clinics and surgery centers that can be independently identified as licensed healthcare entities.
Once an account is verified, ordering moves through the same documentation trail every time: lot numbers, certificates of analysis and donor eligibility summaries are available for each shipment, supporting the patient-level traceability most orthopedic practices already maintain for implanted or injected materials.
Cold chain and receiving in the Midwest
Cryopreserved Wharton's jelly products are stored at -80 degrees Celsius and shipped overnight on dry ice in validated containers. For practices in Youngstown, that means coordinating a receiving window with staff who can move product directly into ultra-low freezer storage without delay.
Lyophilized formats are shelf-stable and do not require that same receiving coordination, which some orthopedic practices find simpler for maintaining inventory between shipments.
Documentation, oversight and getting started
Whether a specific intended use fits within the federal framework for human cell and tissue products is a determination the practice makes with its own counsel, not something Precision Biologics assesses on a clinic's behalf. We recommend practices also confirm their own standing with the Ohio medical board as part of internal compliance review.
To start an account, a practice provides its NPI and licensing information; our team shares the documentation set for the product lines under consideration and can arrange a peer-to-peer conversation focused on paperwork and logistics, not clinical guidance.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Does Precision Biologics work with orthopedic surgery centers in Youngstown specifically?+
We supply licensed orthopedic practices and surgery centers nationally, including in Youngstown, Ohio. Every account is opened the same way: NPI verification followed by review of the documentation set for the products requested.
What documentation should an Ohio orthopedic practice request before ordering?+
At minimum, request the certificate of analysis and donor eligibility summary for the specific lot, along with a description of how the product was processed and tested. Confirm separately with the Ohio medical board and your own counsel whether your intended use fits your practice's regulatory posture.
How long does account verification take for a new Youngstown practice?+
Verification is tied to confirming your NPI and license status, not to location. Once that information is submitted, our team can share documentation and move toward ordering.